Home > Boards > US Listed > Biotechs > Alimera Sciences (ALIM)

I listened to the CC this morning.E Europe is

Public Reply | Private Reply | Keep | Last ReadPost New MsgNext 10 | Previous | Next
bbhuey Member Profile
 
Followed By 7
Posts 612
Boards Moderated 0
Alias Born 11/20/03
160x600 placeholder
Three-Year Clinical Trial Results Support ILUVIENĀ® Launch in Europe for the Prevention of Relapse in Recurrent Non-Infectiou... GlobeNewswire Inc. - 6/6/2019 8:00:00 AM
Current Report Filing (8-k) Edgar (US Regulatory) - 6/4/2019 5:20:39 PM
Alimera Sciences Announces Launch of Direct-to-Patient Marketing Campaign to Raise Awareness and Educate Consumers on Diabeti... GlobeNewswire Inc. - 5/22/2019 8:00:00 AM
Alimera Sciences to Present at the 20th Annual B. Riley FBR Institutional Investor Conference on May 22, 2019 GlobeNewswire Inc. - 5/14/2019 8:05:00 AM
Current Report Filing (8-k) Edgar (US Regulatory) - 5/8/2019 4:37:04 PM
Quarterly Report (10-q) Edgar (US Regulatory) - 5/7/2019 4:43:51 PM
Current Report Filing (8-k) Edgar (US Regulatory) - 5/1/2019 4:35:41 PM
Current Report Filing (8-k) Edgar (US Regulatory) - 4/30/2019 8:10:25 AM
Additional Proxy Soliciting Materials (definitive) (defa14a) Edgar (US Regulatory) - 4/29/2019 4:34:34 PM
Proxy Statement (definitive) (def 14a) Edgar (US Regulatory) - 4/29/2019 4:21:57 PM
Alimera Sciences Announces First Quarter 2019 Financial Results and Provides Corporate Overview GlobeNewswire Inc. - 4/29/2019 4:15:00 PM
Current Report Filing (8-k) Edgar (US Regulatory) - 4/9/2019 5:21:31 PM
Current Report Filing (8-k) Edgar (US Regulatory) - 3/29/2019 4:48:13 PM
Current Report Filing (8-k) Edgar (US Regulatory) - 3/1/2019 4:44:10 PM
Current Report Filing (8-k) Edgar (US Regulatory) - 2/25/2019 5:08:57 PM
Annual Report (10-k) Edgar (US Regulatory) - 2/25/2019 5:03:49 PM
Current Report Filing (8-k) Edgar (US Regulatory) - 2/19/2019 6:36:18 AM
Amended Statement of Ownership (sc 13g/a) Edgar (US Regulatory) - 2/14/2019 5:54:49 PM
Statement of Ownership (sc 13g) Edgar (US Regulatory) - 2/14/2019 5:31:20 PM
Amended Statement of Ownership (sc 13g/a) Edgar (US Regulatory) - 2/14/2019 4:30:48 PM
Amended Statement of Ownership (sc 13g/a) Edgar (US Regulatory) - 2/14/2019 2:55:44 PM
Amended Statement of Ownership (sc 13g/a) Edgar (US Regulatory) - 2/14/2019 11:33:59 AM
Amended Statement of Ownership (sc 13g/a) Edgar (US Regulatory) - 2/14/2019 10:05:04 AM
Amended Statement of Beneficial Ownership (sc 13d/a) Edgar (US Regulatory) - 2/14/2019 6:34:54 AM
bbhuey   Tuesday, 05/09/17 07:02:04 PM
Re: UserBob post# 887
Post # of 926 
I listened to the CC this morning.E Europe
is ahead in orders and more length of experience with US Lagging behind.

The Cincinnati retinal doctor gave a good insight in what he does in the process to use Illivun starting with anti vegf drugs
and other drugs to determine drug reaction before using Illuvin for diabetic patients.I think based upon the longer experience in the EU of ILuven bodes well
for clearing the decks of patients needing
injection every several weeks to 3 years so that more new consults can be treated
and more. profitable.The doctors clinic did 25,000 injections a year. Also he mentioned that the financial handling charge for administering Oralezix will end

All this bodes well for increased usage in the US and Canada.

Public Reply | Private Reply | Keep | Last ReadPost New MsgNext 10 | Previous | Next
Follow Board Follow Board Keyboard Shortcuts Report TOS Violation
X
Current Price
Change
Volume
Detailed Quote - Discussion Board
Intraday Chart
+/- to Watchlist